The addition of zoledronic acid to neoadjuvant chemotherapy may influence pathological response – exploratory evidence for direct anti-tumor activity in breast cancer. - Winter,M.C.; Thorpe,H.C.; Burkinshaw,R. (Cancer Res, 2009)